DICER1 and pancreatic neoplasm: Metformin administration has been associated with the altered expression of miR-26a in pancreatic cancer stem cell markers [129], miR-221 and miR-222 in patients with diabetes mellitus type 2 [131] and DICER1 in a novel therapeutic approach for age-related health problems [138].